Registro:

Referencias:

• Kaufmann, S.H., How can immunology contribute to the control of tuberculosis? (2001) Nat. Rev. Immunol, 1, pp. 20-30
• Tascon, R.E., Stavropoulos, E., Lukaes, K.V., Colston, M.J., Protection against Mycobacterium tuberculosis infection by CDS + T cells requires the production of 7 interferon (1998) Infect. Immun, 66, pp. 830-834
• Zhang, M., Gong, J., Iyer, D.V., Jones, B.E., Modlin, R.L., Barnes, P.F., T cell cytokine responses in persons wilh tuberculosis and human immunodeficiency virus infection (1994) J. Clin. Invest, 94, pp. 2435-2442
• Zhang, M., Lin, Y., Iyer, D.V., Gong, J., Abrams, J.S., Barnes, P.F., T-cell cytokine responses in human infection with Mycobacterium tuberculosis (1995) Infect. Immun, 63, pp. 3231-3234
• Newman, D.K., Hamilton, C., Newman, P.J., Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56tck (2001) Blood, 97, pp. 2351-2357
• Thompson, C.B., Allison, J.P., The emerging role of CTLA-4 as an immune attenuator (1997) Immunity, 7, pp. 445-450
• Oosterwegel, M.A., Greenwald, R.J., Mandelbrot, D.A., Lorsbach, R.B., Sharpe, A.H., CTLA-4 and T cell activation (1999) Curr. Opin. Immunol, 11, pp. 294-300
• Pasquinelli, V., Quiroga, M.F., Martinez, G.J., Zorrilla, L.C., Musella, R.M., Bracco, M.M., Belmonte, L., Garcia, V.E., Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-γ production in human tuberculosis (2004) J. Immunol, 172, pp. 1177-1185
• Quiroga, M.F., Pasquinelli, V., Martinez, G.J., Jurado, J.O., Zorrilla, L.C., Musella, R.M., Abbate, E., Garcia, V.E., Inducible costimulator: A modulator of IFN-γ production in human tuberculosis (2006) J. Immunol, 176, pp. 5965-5974
• Quiroga, M.F., Jurado, J.O., Martinez, G.J., Pasquinelli, V., Musella, R.M., Abbate, E., Issekutz, A.C., Sieling, P.A., Cross-talk between CD31 and the signaling lymphocytic activation molecule-associated protein during interferon-γ production against Mycobacterium tuberculosis (2007) J. Infect. Dis, 196, pp. 1369-1378
• Ishida, Y., Agata, Y., Shibahara, K., Honjo, T., Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death (1992) EMBO J, 11, pp. 3887-3895
• Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubata, T., Yagita, H., Honjo, T., Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes (1996) Int. Immunol, 8, pp. 765-77Z
• Freeman, G.J., Long, A.J., Iwai, Y., Bourque, K., Chemova, T., Nishimura, H., Fitz, L.J., el al, Engagement of the PD-I immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation (2000) J. Exp. Med, 192, pp. 1027-1034
• Latchman, Y., Wood, C.R., Chemova, T., Chaudhary, D., Borde, M., Chemova, I., Iwai, Y., Nunes, R., PD-L2 is a second ligand for PD-1 and inhibits T cell activation (2001) Nat. Immunol, 2, pp. 261-268
• Tseng, S.Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J.E., Pai, S.I., Shalabi, A., Tsuchiya, H., B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells (2001) J. Exp. Med, 193, pp. 839-846
• Sharpe, A.H., Wherry, E.J., Ahmed, R., Freeman, G.J., The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection (2007) Nat. Immunol, 8, pp. 239-245
• Garcia, V.E., Sieling, P.A., Gong, J., Barnes, P.F., Uyemura, K., Tanaka, Y., Bloom, B.R., Modlin, R.L., Single-cell cytokine analysis of γδ T cell responses to nonpeptide myeobacterial antigens (1997) J. Immunol, 159, pp. 1328-1335
• Belts, M.R., Brenchley, J.M., Price, D.A., De Rosa, S.C., Douek, D.C., Roederer, M., Koup, R.A., Sensitive and viable identification of antigen-specific CDS+ T cells by a flow cytometric assay for degranulation (2003) J. Immunol. Methods, 281, pp. 65-78
• Carter, L., Fouser, L.A., Jussif, J., Fitz, L., Deng, B., Wood, C.R., Collins, M., Carreno, B.M., PD-1: PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2 (2002) Eur. J. Immunol, 32, pp. 634-643
• Spellberg, B., Edwards Jr., J.E., Type 1/type 2 immunity in infectious diseases (2001) Clin. Infect. Dis, 32, pp. 76-102
• Chan, E.D., Chan, J., Schluger, N.W., What is the role of nitric oxide in murine and human host defense against tuberculosis: Current knowledge (2001) Am. J. Respir. Cell Mol. Biol, 25, pp. 606-612
• Dorman, S.E., Holland, S.M., Interferon-y and interleukin-12 pathway defects and human disease (2000) Cytokine Growth Factor Rev, 11, pp. 321-333
• Bennett, F., Luxenberg, D., Ling, V., Wang, I.M., Marquette, K., Lowe, D., Khan, N., Valge-Archer, V.E., Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: Attenuation of ICOS, IL-4, and IL-21, but not CD28. IL-7, and IL-I5 responses (2003) J. Immunol, 170, pp. 711-718
• Ellner, J.J., Barnes, P.F., Wallis, R.S., Modlin, R.L., The immunology of tuberculous pleurisy (1988) Semin. Respir. Infect, 3, pp. 335-342
• Loke, P., Allison, J.P., PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 5336-5341
• Zhong, X., Tumang, J.R., Gao, W., Bai, C., Rothstein, T.L., PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for VH11/VH12 and phosphatidylcholine binding (2007) Eur. J. Immunol, 37, pp. 2405-2410
• Chen, L., Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity (2004) Nat. Rev. Immunol, 4, pp. 336-347
• Butte, M.J., Keir, M.E., Phamduy, T.B., Sharpe, A.H., Freeman, G.J., Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses (2007) Immunity, 27, pp. 111-122
• Bukczynski, J., Wen, T., Wang, C., Christie, N., Routy, J.P., Boulassel, M.R., Kovacs, C.M., Sekaly, R.P., Enhancement of HIV-spccific CD8 T cell responses by dual costimulation with CD80 and CD137L (2005) J. Immunol, 175, pp. 6378-6389
• Lee, S.W., Park, Y., Song, A., Cheroutre, H., Kwon, B.S., Croft, M., Functional dichotomy between OX40 and 4-IBB in modulating effector CD8 T cell responses (2006) J. Immunol, 177, pp. 4464-4472
• Dawicki, W., Bertram, E.M., Sharpe, A.H., Watts, T.H., 4-IBB and OX40 act independently to facilitate robust CDS and CD4 recall responses (2004) J. Immunol, 173, pp. 5944-5951
• Hirano, F., Kaneko, K., Tamura, H., Dong, H., Wang, S., Ichikawa, M., Rietz, C., Zhu, G., Blockade of B7-HI and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity (2005) Cancer Res, 65, pp. 1089-1096
• Loke, P., Allison, J.P., Emerging mechanisms of immune regulation: The extended B7 family and regulatory T cells (2004) Arthritis Res. Ther, 6, pp. 208-214
• Dong, H., Zhu, G., Tamada, K., Chen, L., B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion (1999) Nat. Med, 5, pp. 1365-1369
• Barber, D.L., Wherry, E.J., Masopust, D., Zhu, B., Allison, J.P., Sharpe, A.H., Freeman, G.J., Ahmed, R., Restoring function in exhausted CDS T cells during chronic viral infection (2006) Nature, 439, pp. 682-687
• Day, C.L., Kaufmann, D.E., Kiepiela, P., Brown, J.A., Moodley, E.S., Reddy, S., Mackey, E.W., DePierres, C., PD-1 expression on HIV-spccific T cells is associated with T-cell exhaustion and disease progression (2006) Nature, 443, pp. 350-354
• Boettler, T., Panther, E., Bengsch, B., Nazarova, N., Spangenberg, H.C., Blum, H.E., Thimme, R., Expression of the interleukin-7 receptor α chain (CD127) on virus-specific CDS+ T cells identifies functionally and phe-notypically defined memory T cells during acute resolving hepatitis B virus infection (2006) J. Virol, 80, pp. 3532-3540
• Urbani, S., Amadei, B., Tola, D., Massari, M., Schivazappa, S., Missale, G., Ferrari, C., PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-spccific CDS exhaustion (2006) J. Virol, 80, pp. 11398-11403
• Das, S., Suarez, G., Beswick, E.J., Sierra, J.C., Graham, D.Y., Reyes, V.E., Expression of B7-H1 on gastric epithelial cells: Its potential role in regulating T cells during Helicobacter pylori infection (2006) J. Immunol, 176, pp. 3000-3009
• Cohen, N., Morisset, J., Emilie, D., Induction of tolerance by Porphy-romonas gingivalis on APCS: A mechanism implicated in periodontal infection (2004) J. Dent. Res, 83, pp. 429-433
• Sable, S.B., Kumar, R., Kalra, M., Verma, I., Khuller, G.K., Dobos, K., Belisle, J.T., Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis (2005) Infect. Immun, 73, pp. 3547-3558
• Nakae, S., Suto, H., Iikura, M., Kakurai, M., Sedgwick, J.D., Tsai, M., Galli, S.J., Mast cells enhance T cell activation: Importance of mast cell costimulatory molecules and secreted TNF (2006) J. Immunol, 176, pp. 2238-2248
• Garcia, V.E., Quiroga, M.F., Ochoa, M.T., Ochoa, L., Pasquinelli, V., Fainboim, L., Olivares, L.M., Aversa, G., Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns (2001) J. Immunol, 167, pp. 5719-5724
• Okamoto, M., Hasegawa, Y., Hara, T., Hashimoto, N., Imaizumi, K., Shimokata, K., Kawabe, T., T-helpcr type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions (2005) Chest, 128, pp. 4030-4035
• Liang, S.C., Latchman, Y.E., Buhlmann, J.E., Tomczak, M.F., Horwitz, B.H., Freeman, G.J., Sharpe, A.H., Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses (2003) Eur. J. Immunol, 33, pp. 2706-2716
• Flies, D.B., Chen, L., The new B7s: Playing a pivotal role in tumor immunity (2007) J. Immunother, 30, pp. 251-260
• Nishimura, H., Nose, M., Hiai, H., Minato, N., Honjo, T., Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor (1999) Immunity, 11, pp. 141-151
• Latchman, Y.E., Liang, S.C., Wu, Y., Chemova, T., Sobel, R.A., Klemm, M., Kuchroo, V.K., Sharpe, A.H., PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells (2004) Proc. Natl. Acad. Sci, USA, 101, pp. 10691-10696
• Keir, M.E., Liang, S.C., Guleria, I., Latchman, Y.E., Qipo, A., Albacker, L.A., Koulmanda, M., Sharpe, A.H., Tissue expression of PD-L1 mediates peripheral T cell tolerance (2006) J. Exp. Med, 203, pp. 883-895
• Kuipers, H., Muskens, F., Willart, M., Hijdra, D., van Assema, F.B., Coyle, A.J., Hoogsteden, H.C., Lambrecht, B.N., Contribution of the PD-1 ligands/PD-I signaling pathway to dendritic cell-mediated CD4+ T cell activation (2006) Eur. J. Immunol, 36, pp. 2472-2482
• Blocki, F.A., Radhakrishnan, S., Van Keulen, V.P., Heckman, K.L., Ciric, B., Howe, C.L., Rodriguez, M., Pease, L.R., Induction of a gene expression program in dendritic cells with a cross-linking IgM antibody to the co-stimulatory molecule B7-DC (2006) FASEB J, 20, pp. 2408-2410
• Rodig, N., T. Ryan, J. A. Allen, H. Pang, N. Grabie, T. Chemova, E. A. Greenfield, S. C. Liang, A. H. Sharpe, A. II. Lichtman, and G. J. Freeman. 2003. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ Tcell activation and cytolysis. Eur. J. Immunol. 33: 3117-3126; Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800; Hadrup, S.R., Braendstrup, O., Jacobsen, G.K., Mortensen, S., Pedersen, L.O., Seremet, T., Andersen, M.H., Straten, P.T., Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells (2006) Int. J. Cancer, 119, pp. 831-838
• Mittendorf, E.A., Storrer, C.E., Shriver, C.D., Ponniah, S., Peoples, G.E., Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides (2005) Breast Cancer Res. Treat, 92, pp. 85-93
• Petrovas, C., Casazza, J.P., Brenchley, J.M., Price, D.A., Gostick, E., Adams, W.C., Precopio, M.L., Koup, R.A., PD-1 is a regulator of virus-specific CDS+ T cell survival in HIV infection (2006) J. Exp. Med, 203, pp. 2281-2292
• Trautmann, L., Janbazian, L., Chomont, N., Said, E.A., Gimmig, S., Bessette, B., Boulassel, M.R., Balderas, R.S., Upregulation of PD-1 expression on HIV-specific CDS+ T cells leads to reversible immune dysfunction (2006) Nat. Med, 12, pp. 1198-1202
• Jun, H., Seo, S.K., Jeong, H.Y., Seo, H.M., Zhu, G., Chen, L., Choi, I.H., B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK) (2005) FEBS Lett, 579, pp. 6259-6264
• Maier, H., Isogawa, M., Freeman, G.J., Chisari, F.V., PD-1: PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver (2007) J. Immunol, 178, pp. 2714-2720
• Wolf, A.J., Desvignes, L., Linas, B., Banaiee, N., Tamura, T., Takatsu, K., Emst, J.D., Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs (2008) J. Exp. Med, 205, pp. 105-115
• Alfaro, C., Murillo, O., Tirapu, I., Azpilicueta, A., Huarte, E., Anna, A., Arribillaga, L., Prieto, J., The im-munotherapy potential of agonistic anti-CD 137 (4-IBB) monoclonal antibodies for malignancies and chronic viral diseases] (2006) An. Sist. Sanit. Navar, 29, pp. 77-96

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------